Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELAS PHARMACIE BEATRICE JOLY : revenue, balance sheet and financial ratios

SELAS PHARMACIE BEATRICE JOLY is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in AUBIGNY-SUR-NERE (18700), this company of category PME shows in 2024 a net income positive of 472 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE BEATRICE JOLY (SIREN 820628840)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 471 792 € 471 596 € 517 367 € 298 990 € 454 285 € 110 319 € 179 946 € 395 425 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELAS PHARMACIE BEATRICE JOLY generates positive net income of 472 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 395 k€ -> 472 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

471 792 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 31%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

31.315%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

68.929%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

35.5%

Solvency indicators evolution
SELAS PHARMACIE BEATRICE JOLY

Sector positioning

Debt ratio
31.32 2024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Good -13 pts over 3 years

In 2024, the debt ratio of SELAS PHARMACIE BEATRICE ... (31.32) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
68.93% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +19 pts over 3 years

In 2024, the financial autonomy of SELAS PHARMACIE BEATRICE ... (68.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 505.73. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

505.734

Liquidity indicators evolution
SELAS PHARMACIE BEATRICE JOLY

Sector positioning

Liquidity ratio
505.73 2024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent

In 2024, the liquidity ratio of SELAS PHARMACIE BEATRICE ... (505.73) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of SELAS PHARMACIE BEATRICE JOLY in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SELAS PHARMACIE BEATRICE JOLY is estimated at 6 586 565 € (range 4 586 779€ - 9 853 878€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
4586k€ 6586k€ 9853k€
6 586 565 € Range: 4 586 779€ - 9 853 878€
NAF 5 année 2024

Valuation method used

Net Income Multiple
471 792 € × 14.0x = 6 586 565 €
Range: 4 586 780€ - 9 853 878€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE BEATRICE JOLY with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE BEATRICE JOLY

What is the revenue of SELAS PHARMACIE BEATRICE JOLY ?

The revenue of SELAS PHARMACIE BEATRICE JOLY is not publicly disclosed (confidential accounts filed with INPI).

Is SELAS PHARMACIE BEATRICE JOLY profitable?

Yes, SELAS PHARMACIE BEATRICE JOLY generated a net profit of 472 k€ in 2024.

Where is the headquarters of SELAS PHARMACIE BEATRICE JOLY ?

The headquarters of SELAS PHARMACIE BEATRICE JOLY is located in AUBIGNY-SUR-NERE (18700), in the department Cher.

Where to find the tax return of SELAS PHARMACIE BEATRICE JOLY ?

The tax return of SELAS PHARMACIE BEATRICE JOLY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE BEATRICE JOLY operate?

SELAS PHARMACIE BEATRICE JOLY operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.